Pediatric ophthalmologists analyze the FDA Advisory Committee review of SYD-101 low-dose atropine and define the clinical boundaries of genetic testing in myopia.

A new study reveals that personal habits and neighborhood deprivation are the biggest barriers to glaucoma medication compliance, outweighing health care system obstacles.

The American Academy of Pediatrics issued a new policy statement detailing key guidelines for developers, health systems, and clinicians on the safe and ethical use of generative AI in pediatric …

A new North American guideline provides 13 conditional recommendations for managing bronchiectasis in adults. Based on a systematic review of 47 studies, the guidance addresses antibiotic duration, sputum testing, airway …

A new multicountry study found higher rates of hair loss, scalp inflammation and nail disorders among GLP-1 receptor agonist users with obesity or type 2 diabetes. Researchers reported increased nail …

  Headline Merck discontinues Recarbrio in the U.S., raising concerns about treatment options for difficult-to-treat Gram-negative infections Merck has discontinued production and U.S. marketing of Recarbrio (imipenem/cilastatin/relebactam), an intravenous antibacterial …